The mission of the Biostatistics Shared Resource is to provide strategic service in the design, oversight, implementation, analysis, publication, and reporting of scientific studies by CCSG program members. This includes articulating study objectives and hypotheses, conceiving appropriate cost-effective designs and models for achievement of study objectives, assuring that modern and appropriate statistical methods are used, monitoring interim and final analyses, and co-authoring abstracts and manuscripts. The expertise provided by the staff ensures that the yield of useful information from scientific studies is maximized while the costs are minimized. With leadership including William Brady, PhD (ET) as Resource Director; Alan Hutson, PhD (ET), as Chair of RPCI's Department of Biostatistics and Bioinformatics; Gregory Wilding, PhD (GU), as departmental Vice Chair for Biostatistics and Resource Co-Director; and several newly appointed PhD biostatisticians, the Resource has continued to expand upon its technical, collaborative, and administrative expertise. Dr. Hutson (ET) is also Chair of Biostatistics at the State University of New York at Buffalo (UB); and the Biostatistics Shared Resource is a joint effort between the RPCI and UB departments. The Biostatistics Resource and the Bioinformatics Resource (Song Liu, PhD (GN), Vice-Chair for Bioinformatics and Resource Director) coordinate several research activities through regular planning meetings. The expertise within the Resource spans the full range of biostatistics (from preclinical studies to clinical trials, epidemiology, and diagnostic tests), molecular epidemiology, and statistical genetics and genomics. The Resource is fully ingrained in the scientific collaborative process with CCSG members throughout the Institute, and further usage is fostered by numerous mechanisms, including: referrals, the Scientific Review Committee's requirement that protocols have input from a biostatistician, mandates by funding agencies that proposals include proper statistical designs, formal seminars given by Resource staff, and presentations at CCSG Program meetings. First priority for use of the Biostatistics Shared Resource is given to peer-review-funded CCSG members; second to non-peer-review-funded CCSG members; third to non-members and academic collaborators; and lastly to external users. During the reporting period, the Biostatistics Shared Resource served 119 members, with 34% utilization by CCSG members with peer reviewed funding. The CCSG support provides 22% of the overall proposed budget.

Public Health Relevance

Rigorous biostatistics is central to all aspects of cancer research. The Biostatistics Shared Resource plays a central role in the design, analysis, and interpretation of basic science, clinical, and population-based cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-40
Application #
9273398
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
2017-05-01
Budget End
2018-04-30
Support Year
40
Fiscal Year
2017
Total Cost
$276,761
Indirect Cost
$52,981
Name
Roswell Park Cancer Institute Corp
Department
Type
Independent Hospitals
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Block, Matthew S; Vierkant, Robert A; Rambau, Peter F et al. (2018) MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clin Proc 93:307-320
Li, Qiuhui; Deng, Qu; Chao, Hsueh-Ping et al. (2018) Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nat Commun 9:3600
Rossetti, Stefano; Wierzbicki, Andrzej J; Sacchi, Nicoletta (2018) Undermining ribosomal RNA transcription in both the nucleolus and mitochondrion: an offbeat approach to target MYC-driven cancer. Oncotarget 9:5016-5031
Mett, V; Komarova, E A; Greene, K et al. (2018) Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy. Oncogene 37:439-449
Long, Mark D; Singh, Prashant K; Russell, James R et al. (2018) The miR-96 and RAR? signaling axis governs androgen signaling and prostate cancer progression. Oncogene :
Kawaguchi, Tstutomu; Yan, Li; Qi, Qianya et al. (2018) Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer. Ann Surg Oncol 25:4037-4046
Mussell, Ashley L; Denson, Kayla E; Shen, He et al. (2018) Loss of KIBRA function activates EGFR signaling by inducing AREG. Oncotarget 9:29975-29984
Hirose, Yuki; Nagahashi, Masayuki; Katsuta, Eriko et al. (2018) Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis. Sci Rep 8:10814
Vexler, Albert; Yu, Jihnhee; Zhao, Yang et al. (2018) Expected p-values in light of an ROC curve analysis applied to optimal multiple testing procedures. Stat Methods Med Res 27:3560-3576
Samuel, Sandeep; Mukherjee, Sarbajit; Ammannagari, Nischala et al. (2018) Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study. PLoS One 13:e0198809

Showing the most recent 10 out of 1555 publications